We examined associations of eight SNPs in/near seven candidate genes with glycemic response to 6 month treatment with DPP4 inhibitors. 206 patients with type 2 diabetes (116 men and 90 women) were treated with sitagliptin or vildagliptin (both 100 mg/day) in combination with metformin or metformin/sulphonylurea over 6 months, and the reduction in glycated hemoglobin (HbA) was measured. Rs6923761 in was significantly associated with a reduction in HbA (adjusted p = 0.006). Homozygotes for the minor A allele had smaller reduction in HbA by 0.4% (4 mmol/mol) than the G allele carriers (p = 0.016). The missense variant rs6923761 in the gene was associated with a smaller glycemic response to 6 month gliptin therapy in diabetic patients of central European origin.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2217/pgs-2019-0147 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Fighting Fire with Fire: Impact of Sugary Diets on Metabolically Deranged Mice.
Nutrients
December 2024
Department of Neuroscience & Behavior, Barnard College, Columbia University, New York, NY 10027, USA.
There is controversy about the health risks of sugary diets. A recent study reported that chronic consumption of 11% sugar solutions improved glycemic control in lean mice. Based on this finding, we hypothesized that chronic consumption of the same 11% sugar solutions would also improve glycemic control in metabolically deranged mice.
View Article and Find Full Text PDFEffect of Long-Term Taurine Supplementation on the Lipid and Glycaemic Profile in Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis.
Nutrients
December 2024
School of Exercise and Health, Shanghai University of Sport, Shanghai 200438, China.
Background: Taurine has been demonstrated to regulate and improve metabolic health. However, physiological and pathological differences among individuals with overweight or obesity may result in varied responses to taurine supplementation. This study aims to estimate the effects of long-term taurine supplementation on blood lipids, glycemia, and insulin sensitivity in adults with overweight or obesity through a systematic review and meta-analysis.
View Article and Find Full Text PDFThe Influence of Rice Types and Boiling Time on Glycemic Index: An In Vivo Evaluation Using the ISO 2010 Method.
Foods
December 2024
Faculty of Food Technology, Technical University of Moldova, 168, Stefan cel Mare bd, MD-2004 Chisinau, Moldova.
Effective blood glucose management is essential for individuals with type 1 diabetes, particularly when dietary adjustments involve staple foods like rice. As a primary carbohydrate worldwide, rice significantly influences the glycemic index (GI) based on its type and cooking method. This study investigated the impact of rice type and boiling duration on the GI in healthy adults using an in vivo approach aligned with ISO 2010 standards.
View Article and Find Full Text PDFManaging cardiovascular events, hyperglycemia, and obesity in type 2 diabetes through microRNA regulation linked to glucagon-like peptide-1 receptor agonists.
Diabetol Metab Syndr
January 2025
Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran.
Background And Aims: Type 2 diabetes mellitus (T2DM) is usually complicated by cardiovascular diseases, hyperglycemia, and obesity, which worsen the outcome for the patient. Since recent evidence underlines the epigenetic role of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in the management of these comorbidities, this study compared the effects of these agents, namely liraglutide, semaglutide, dulaglutide, and exenatide, on miRNA regulation in the management of T2DM.
Results: GLP-1RAs modify the expression of miRNAs involved in endothelial function, sugar metabolism, and adipogenesis, including but not limited to miR-27b, miR-130a, and miR-210.
Impact of digital health interventions on glycemic control and weight management.
NPJ Digit Med
January 2025
January AI, Menlo Park, CA, USA.
This retrospective cohort study evaluates the impact of an AI-supported continuous glucose monitoring (CGM) mobile app ("January V2") on glycemic control and weight management in 944 users, including healthy individuals and those with prediabetes or type 2 diabetes (T2D). The app, leveraging AI to personalize feedback, tracked users' food intake, activity, and glucose responses over 14 days. Significant improvements in time in range (TIR) were observed, particularly in users with lower baseline TIR.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!